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LAY ABSTRACT
This report from a European multicentre, prospective, 
observational, open-label, exploratory study examines 
the effects of gait training using an exoskeleton (Ekso 
Bionics) after spinal cord injury on spasticity, pain, range 
of motion, bowel and lower urinary tract function, acti-
vities of daily living and quality of life. Exoskeleton gait 
training seemed to be well-tolerated in spinal cord injury 
participants with neuropathic and nociceptive pain, but 
pain did not change during 8 weeks of training. Compa-
red with testing prior to a single training session, spas-
ticity decreased after training when calculating a sum-
score for multiple lower extremity muscle groups. The 
results indicate a benefit in terms of independence mea-
sure SCIM III as well as quality of life over time. Bowel 
and lower urinary tract function did not change overall. 
Future studies could investigate these parameters com-
pared with traditional gait training for spinal cord injury, 
as well as testing more intensive training protocols.
Objective: To explore changes in pain, spasticity, 
range of motion, activities of daily living, bowel and 
lower urinary tract function and quality of life of in-
dividuals with spinal cord injury following robotic 
exoskeleton gait training. 
Design: Prospective, observational, open-label mul-
ticentre study.
Methods: Three training sessions per week for 8 
weeks using an Ekso GT robotic exoskeleton (Ekso 
Bionics). Included were individuals with recent (<1 
year) or chronic (>1 year) injury, paraplegia and te-
traplegia, complete and incomplete injury, men and 
women. 
Results: Fifty-two participants completed the train-
ing protocol. Pain was reported by 52% of partici-
pants during the week prior to training and 17% 
during training, but no change occurred longitudinal-
ly. Spasticity decreased after a training session com-
pared with before the training session (p < 0.001), 
but not longitudinally. Chronically injured partici-
pants increased Spinal Cord Independence Measure 
(SCIM III) from 73 to 74 (p = 0.008) and improved 
life satisfaction (p = 0.036) over 8 weeks of training. 
Recently injured participants increased SCIM III 
from 62 to 70 (p < 0.001), but no significant change 
occurred in life satisfaction. Range of motion, bowel 
and lower urinary function did not change over time.
Conclusion: Training seemed not to provoke new 
pain. Spasticity decreased after a single training ses-
sion. SCIM III and quality of life increased longitudi-
nally for subsets of participants.
Key words: exoskeleton; spinal cord injury; rehabilitation; 
pain; spasticity; SCIM III.
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Spinal cord injury (SCI) gives rise to a large number of secondary health conditions, including pain (1, 
2), spasticity (2, 3) decreased range of motion (ROM) 
(3), decreased independence (4), bowel (5) and bladder 
dysfunction (6), and decreased quality of life (QoL) 
(7). Among individuals with SCI, these issues should 
be addressed with high priority (8, 9), as many of the 
secondary health conditions have been shown to be 
independently associated with decreased QoL (10, 11). 
Exoskeleton training has been developed as a reha-
bilitation tool and is approved for the rehabilitation of 
individuals with SCI. Gait function has often been the 
focus of studies, but indications of improvements in 
pain, spasticity, bowel and bladder function have also 
been reported (12–14). However, further studies are 
needed. Several commercial exoskeletons are currently 
available (15). The exoskeleton used for this study was 
the Ekso GT robotic (Ekso Bionics, Richmond, CA, 
JR
M
JR
M
Jo
ur
na
l o
f 
R
eh
ab
ili
ta
ti
on
 M
ed
ic
in
e
JR
M
Jo
ur
na
l o
f 
R
eh
ab
ili
ta
ti
on
 M
ed
ic
in
e
807Exoskeleton gait training after SCI
USA) exoskeleton. A characteristic of this exoskeleton 
is, among others, that initiation of a new step can be 
controlled by the user via sensors in the foot-plates that 
capture the weight transfer between the left and right 
legs. Power from the on-board motors controlling leg 
movement can be adjusted to accommodate the user’s 
needs. An assistive device, walker or crutches, are 
always used for balance.
The safety and feasibility of the training protocol 
for this study and changes in outcomes of gait and 
balance have been published separately (16). The initial 
publication documented that the training was safe with 
no serious adverse events and that the protocol was 
feasible for all of the subgroups of included partici-
pants, i.e. recently and chronically injured individuals 
with paraplegia and tetraplegia, as well as those with 
complete and incomplete injury. There was progression 
over the 8 weeks in the time walking in the exoskeleton 
and the number of steps taken during the training ses-
sions. The training was light to moderate in intensity. 
Lastly, there were indications of improvements in gait 
function and balance outside of the exoskeleton for 
individuals with incomplete SCI. 
The objective of the present study was to explore 
changes in pain, spasticity, range of motion (ROM), 
Spinal Cord Independence Measure (SCIM III), bowel 
and lower urinary tract (LUT) function, and quality of 
life (QoL) in individuals with SCI following robotic ex-
oskeleton gait training with Ekso GT, in order to guide 
future randomized controlled trials (RCT) and explore 
areas of potential benefit from exoskeleton training.
METHODS 
This study followed individuals with SCI over an 8-week train-
ing period with an exoskeleton from Ekso GT (Ekso Bionics, 
Richmond, CA, USA) as an adjunct to therapy. Changes in pain, 
spasticity, ROM, SCIM III, bowel and LUT function and QoL, 
over the training period and at a follow-up were documented, 
in addition to spasticity pre- and post-training. 
Study design
The study was a prospective, observational, open-label, multi-
centre study. The 9 European SCI rehabilitation centres were 
located in Denmark, Germany, the Netherlands, Norway, Spain, 
Sweden and Switzerland. 
Training protocol and participants
The training protocol consisted of 24 robotic exoskeleton gait 
training sessions (TSs) of 1 h, 3 times per week for 8 conse-
cutive weeks. Prior to commencing the study, researchers and 
therapists from the 9 centres joined a 2-day kick-off meeting. 
The study protocol and all tests were reviewed systematically, 
to ensure that all therapists agreed on performance of the tests 
and data collection. Participants were recruited as a convenience 
sample at each centre and screened and included according to 
the eligibility criteria listed in Table I (16).
Participant characteristics were collected according to the 
International SCI Core Data Set Version 1.1 (17, 18). The fol-
lowing 2 groups were defined; “recently injured” (Time since 
injury, TSI ≤1 year) and “chronically injured” (TSI >1 year). 
The rationale for this division in analysis was that some degree 
of neurological recovery would be expected in the early phase 
after injury, whereas this is less likely to happen in the chronic 
phase (19–21). 
The training frequency of 3 times per week was based on 
general recommendations of training frequency and duration 
frequencies of (3–5 times per week with duration of 20–60 
Table I. Eligibility criteria (16)
Inclusion criteria Exclusion criteria
A traumatic or non-traumatic SCI with either motor complete (AIS A or B) with 
NLI from C7 to L2 (inclusive) or motor incomplete (AIS C and D) with NLI from 
C1 to L2 (inclusive), as determined by the ISNCSCI
Previous training with an exoskeleton and other types of robotic assisted gait 
training
Age 15–65 years at time of entry to the trial (some centres 18–65 years) Spinal instability
More than 30 days since injury (TSI) Acute deep vein thrombosis
Body height 157–188 cm OR max hip width 42 cm, upper leg length 51–61.4 
cm and lower leg length 48–63.4 cm
Severe, recurrent attacks of autonomic dysreflexia requiring medical 
intervention 
Maximum body weight 100 kg Heterotopic ossification in the lower extremities resulting in restrictions of ROM 
at the hip or knee
Sufficient upper extremity strength to use a front-wheeled walker Two or more pathological fractures in the last 48 months in a major weight-
bearing bone in the lower extremity (femur or tibia) 
Sufficient range of motion to achieve a reciprocal gait pattern and to perform 
sit-to-stand transition in the device
Hip subluxation 
Medically stable and cleared by a physician for full weight bearing locomotor 
training
Cognitive deficits that limit the participant to understand instructions and 
safely participate in a training programme, evaluated by investigator
Standing orthostatic tolerance trial by standing for 15 min, fully supported in a 
standing-frame, while measuring blood pressure regularly 
Spasticity assessed with the Modified Ashworth Scale = 4 in lower extremity 
muscles 
Skin integrity issues in areas in contact with the device
Concurrent neurological injury or any other issue that in the opinion of the 
investigator would confound the results
Pregnancy
AIS: American Spinal Injury Association [ASIA] impairment scale; SCI: spinal cord injury; NLI: Neurological Level of Injury; ISNCSCI: International Standards 
for Neurological Classification of SCI.
J Rehabil Med 50, 2018
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808 C. B. Baunsgaard et al.
min) (22) and has commonly been used in similar exoskeleton 
studies (23). A 1-h session was estimated to be feasible from 
clinical experience at the included sites. 
The study did not control for other types of training that 
individuals attended.
Assessments
The included tests and time-points are specified below. All tests 
for changes over time were performed before training at baseline 
and at the end of the 8-week training period, i.e. training session 
24 (TS24). Pain and spasticity were, in addition, also assessed 
midway before training at session 12 (TS12). Assessments 
were repeated, at a follow-up session 4 weeks after the final 
training session, in order to assess whether potential changes 
were retained. Pain and spasticity were furthermore assessed 
immediately after the training session (details below).
Pain. Pain was assessed with the International SCI Pain Basic 
Data Set (version 2.0) (24) in 2 versions. The original version 
asked about levels of pain experienced during the last 7 days, 
prior to the training. The second version was modified by asking 
about pain experienced during the training, assessed imme-
diately after the session. Every episode of pain was recorded, 
according to the International SCI Pain Basic Data Set, in terms 
of location, type and intensity. Participants could report up to 3 
types of pain at each time-point. The type of pain was classified 
as either neuropathic or nociceptive. 
Spasticity. The Modified Ashworth Scale (MAS) was used to 
assess spasticity. The following muscle groups were tested bi-
laterally: hip flexors and extensors, knee flexors and extensors, 
ankle dorsi-flexors and plantar flexors, 12 muscle groups in total. 
MAS assessments were performed immediately before training 
at baseline, TS12, TS24, and follow-up to assess changes over 
time. At TS12 and TS24, MAS was also tested immediately after 
the training session to assess changes pre-post a single training 
session. For statistical analysis, MAS was considered an ordinal 
scale. As a measure of overall spasticity, the sum-score of all 
12 muscle groups was calculated for each person, at each time-
point (0–60 scale). The calculated sum-score of MAS used in 
the analysis has not been validated, but a similar approach with 
a sum-score of spasticity has been described and used previously 
(25). If the MAS assessment triggered clonus, the measure was 
treated as a missing value, since the MAS scale does not include 
clonus, but rather describes increased tone or resistance against 
a passive movement. For calculation of the MAS sum-score, in 
case of clonus, all measures at other time-points for the same 
muscle were removed (list-wise deleting) to avoid an unbalanced 
sum-score when comparing different time-points.
Range of motion. ROM was measured by goniometry and 
assessed at baseline, TS24 and follow-up, bilaterally on the 
following lower extremity joint-movements: hip flexion, hip 
extension, knee flexion, knee extension, ankle dorsiflexion, 
and ankle plantarflexion. ROM was included, in order to assess 
potential mobility changes over time, as well as in conjunction 
with spasticity measures.
Spinal Cord Independence Measure. SCIM III (26, 27) was as-
sessed for all participants at baseline, TS24 and follow-up. The 
subtotal-scores of Self-Care (0–20), Respiration and Sphincter 
Management (0–40), Mobility (0–40) and the total SCIM III-
score (0–100) were used for analyses.
Bowel, lower urinary tract function and quality of life. The 
International SCI Basic Data Sets were used to assess bowel 
function (28), LUT function (29) and QoL (30). 
All the International SCI Basic Data Sets were translated into 
the local language, according to recommendations (31). The 
International SCI Basic Data Sets can be found on the ISCoS 
homepage (http://www.iscos.org.uk/international-sci-data-sets).
Statistical analysis
Median and interquartile ranges (IQR) were used for descriptive 
statistics. Changes in paired, nominal data were analysed with 
McNemar’s test. Repeated measures of intensity of pain, MAS, 
ROM, SCIM III and QoL were analysed with Wilcoxon signed-
rank test and Bonferroni corrected for multiple comparisons of 
the repeated measures. Non-parametric statistics (McNemar’s 
test and Wilcoxon signed-rank test) were also used for the 
analysis of change in MAS before and after a single training 
session at TS12 and TS24, the International SCI Bowel and 
Lower Urinary Tract Function Basic Data Sets. Significance 
level was set to α = 0.05. Statistical analysis was performed with 
IBM SPSS Statistics version 22 (IBM Corp. Released 2013. 
Armonk, NY, USA). 
Statement of ethics
All applicable institutional and governmental regulations 
concerning the ethical use of human volunteers were followed 
during the course of this research. All the necessary approvals 
were obtained in each centre, including local ethics committee 
approvals. All participants received oral, as well as written 
information about the study, before written consent was ob-
tained. The study followed the guidelines of the Declaration 
of Helsinki. The study was registered at ClinicalTrials.gov 
(identifier: NCT02132702).
RESULTS
The study was performed from April 2014 to March 
2016. A total of 52 participants completed the training. 
Participant characteristics are shown in Table II. A 
training session was up to 1 h and the median (IQR) 
was 31.5 min (24.5–39.0 min) over the 8 weeks of 
training (16).
Pain
Fig. 1A shows the number of participants who reported 
presence of pain in the week prior to training and Fig. 
1B shows the number of participants who reported 
presence of pain during the exoskeleton training ses-
sion. Pain in the week prior to training and during 
training (TS1, TS12 and TS24) was not always present, 
and thus was not reported by the same participants. 
Presence of pain in the previous week, at all 4 time-
points (TS1, TS12, TS24, follow-up), was reported 
by 21 participants (40%), pain at 1, 2 or 3 time-points 
was reported by 15 (29%) and no pain at any time was 
www.medicaljournals.se/jrm
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809Exoskeleton gait training after SCI
reported by 16 (31%). Pain during all TSs was reported 
by 2 participants (4%), 4 participants (8%) had pain 
at 2 of the TSs and 13 (25%) reported pain at 1 of the 
3 TSs where pain was surveyed.
There was no statistical difference, in either recently 
or chronically injured participants, from TS1 to TS24, 
or to follow-up of interference of pain on day-to-day 
activities, overall mood, ability to get a good night’s 
sleep or in the number of pain problems experienced 
in the previous week. 
Seven participants reported neuropathic pain during 
training at TS1, TS12 and TS24, while 15 reported 
nociceptive pain, with an overlap of 4 participants who 
experienced both types of pain. Locations for nocicep-
tive pain were; lower back (n = 7), upper back (n = 1), 
shoulder (n = 3), hip (n = 2) and knee (n = 2). Locations 
of neuropathic pain during training were; thigh and 
lower extremity (n = 4), lower back and hip (n = 3). 
When analysing the participants individually, the 
pain reported during training had the same location 
and was of the same type as pain reported between 
TSs in the previous week. The only exceptions to this 
were 2 participants who reported pain in the hip and 
shoulder during their first training session, but did not 
report pain in the previous week. 
Spasticity 
Fig. 2 shows the MAS sum-score before and after a 
single training session at TS12 and at TS24. There was 
a significant reduction in spasticity on the MAS sum-
score from pre- to post-training at both TS12 and TS24 
sessions after Bonferroni correction (p = 0.05/2=0.025). 
The results at TS12 were a median (IQR) decrease from 
4 (0–16) to 2 (0–10), p < 0.001 and at TS24 a decrease 
from 5 (0–14) to 2 (0–9), p < 0.001. In 8 participants, 
the movement of the ankle plantar flexors triggered 
clonus; thus, as it was not possible to rate on the MAS, 
the data-points were excluded from analysis. Statistical 
testing was done only on the MAS sum-score of the 12 
muscle groups (6 muscle groups bilaterally), but all of 
the 12 muscle groups decreased on the MAS sum-score 
from before to after the training session at TS12 and 
TS24, calculated as rank scores. 
No significant difference was found in MAS longi-
tudinally from baseline to TS24 or follow up, in either 
the recently, or the chronically injured group.
Range of motion 
No differences in ROM were detected between base-
line, TS24 and follow-up.
Spinal Cord Independence Measure 
The results of the SCIM III for recently injured and 
chronically injured participants are shown in Table III. 
Table II. Participant characteristics, n = 52
Characteristics
Age, years, median (IQR) 35.8 (27.5–52.6)
Sex, n (%)
   Men 36 (69.2)
   Woman 16 (30.8)
BMI, kg/m2, median (IQR) 24.1 (22.0–26.2)
Time since injury, year, n (%); median (IQR)
Recently injured (TSI ≤ 1 year) 25 (48); 0.3 (0.2–0.4)
Chronically injured (TSI > 1 year) 27 (5); 5.5 (2.1–10.8)
Spinal cord injury aetiology, n (%)
   Sport/leisure 16 (30.8)
   Assault 2 (3.8)
   Transport 17 (32.7)
   Fall 7 (13.5)
   Other traumatic cause 1 (1.9)
   Non-traumatic spinal cord dysfunction 9 (17.3)
NLI and severity of injury at baseline, n (%)
   C1–C4 AIS A, B, C 0 (0)
   C5–C8 AIS A, B, C 4 (7.7)
   T1–S5 AIS A, B, C 29 (55.8)
   All AIS D 19 (36.5)
Grouping of neurological injury, n (%)
Motor complete tetraplegia 
C7–C8, AIS A and B 3 (5.8)
Motor incomplete tetraplegia 
C2–C8, AIS A and B 11 (21.2)
Motor complete paraplegia 
T1–L2, AIS A and B 22 (42.3)
Motor incomplete paraplegia 
T1–L2, AIS C and D 16 (30.8)
IQR: interquartile range; NLI: neurological level of injury; BMI: body mass 
index; AIS: American Spinal Injury Association Impairment Scale; TSI: time 
since injury.
Fig. 1. Presence of pain in the last week and pain during exoskeleton 
training, n = 52. TS: training session; FU: follow-up.
Fig. 2. Modified Ashworth Scale (MAS) before and after a single training 
session, n = 51. CI: confidence interval.
J Rehabil Med 50, 2018
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injured group did not change significantly over time, 
whereas, satisfaction with life as a whole was found 
to increase significantly for the chronically injured 
group from baseline to TS24 (p = 0.03), as well as to 
follow-up (p = 0.01).
DISCUSSION
This study aimed to assess changes in pain, spasti-
city, ROM, SCIM III, QoL, bowel and LUT function, 
during a period of gait training using an exoskeleton. 
The main findings were short-term reductions in lower 
extremity spasticity and, for a subset of participants, 
there were improvements over time in SCIM III and 
QoL. There were no significant longitudinal changes on 
the other outcomes. The importance of early interven-
tion is well established and there are no results from 
this study indicating that this training modality could 
not be initiated in the early phase of rehabilitation. 
To ensure this recommendation, further studies need 
to be carried out. Furthermore, also, the chronically 
injured participants (TSI > 1 year) seemed to benefit 
on some parameters from the training, indicating that 
the exoskeleton training might be well-suited, both for 
persons with recent, and those with chronic, injuries.
The recently injured group improved significantly 
on the total SCIM III score, as well as on all sub-cate-
gories. The “Respiration and Sphincter Management” 
sub-category did not change on the bladder score, but 
increased on the bowel and use of toilet score. 
The chronically injured group improved signifi-
cantly on the total SCIM III score, with a median 
increase of 1 point. Out of all sub-categories scores, 
the “Respiration and Sphincter Management” was 
the only one with a significant increase. Within that 
sub-category, “Use of Toilet” had the largest change. 
Bowel function and lower urinary tract function on 
the International SCI Basic Data Sets
Within the item “awareness of the need to defecate”, 
improvements were seen in 6 out of 25 participants 
of the recently injured group and none worsened. The 
chronically injured did not change on this item. No sig-
nificant differences over time were found on outcomes 
measuring either bowel or LUT function.
Quality of life 
Results for recently and chronically injured parti-
cipants are shown in Table IV. QoL in the recently 
Table III. Spinal cord independence measure III
Baseline
Median (IQR)
TS24 
Median (IQR)
Follow-up 
Median (IQR)
Baseline–TS24 
p-value
Baseline–Follow-up 
p-value
Recently injured (n = 25)
   Self-care 18 (14.5–19.5) 18 (16.0–20.0) 18 (16.0–19.0) 0.006 0.025
   Respiration and sphincter management 30 (23.5–35.5) 33 (30.5–36.0) 34 (31.5–36.0) 0.001 < 0.001
   Mobility 16 (13.0–18.5) 19 (16.5–24.5) 19 (15.5–26.5) < 0.001 < 0.001
   Total score 62 (51.0–73.0) 70 (65.0–77.0) 73 (67.5–78.0) < 0.001 < 0.001
Chronically injured (n = 27)
   Self-care 18 (17.0–19.0) 18 (17.0–19.0) 18 (17.0–20.0) 0.280 0.189
   Respiration and sphincter management 35 (30.0–37.0) 35 (33.0–38.0) 36 (33.0–37.0) 0.027 0.010
   Mobility 19 (16.0–23.0) 19 (17.0–25.0) 19 (17.0–23.0) 0.064 0.297
   Total score 73 (64.0–77.0) 74 (68.0–81.0) 74 (71.0–78.0) 0.008 0.014
IQR: interquartile range; TS24: training session 24.
Table IV. Quality of life
Baseline 
Median (IQR)
TS24 
Median (IQR)
Follow-up 
Median (IQR)
Baseline–TS24 
p-value
Baseline–Follow-up 
p-value
Recently injured (n = 25)
   Satisfaction with life as a wholea 5 (3.0–7.0) 6 (4.5–8.0) 6 (4.0–8.0) 0.101 0.079
   Satisfaction with physical healthb 6 (3.5–7.5) 7 (4.5–8.0) 6 (4.0–7.0) 0.129 0.363
   Satisfaction with psychological health, emotions and moodc 7 (5.0–8.0) 5 (4.0–8.0) 7 (4.0–8.0) 0.073 0.636
Chronically injured (n = 27)
   Satisfaction with life as a wholea 6 (5.0–7.0) 7 (6.0–9.0) 8 (7.0–8.00) 0.036 0.010
   Satisfaction with physical healthb 7 (6.0–8.0) 7 (6.0–8.0) 7 (4.0–8.0) 0.279 0.329
   Satisfaction with psychological health, emotions and moodc 7 (6.0–9.0) 8 (7.0–8.0) 7.5 (5.75–8.0) 0.080 0.273
aSatisfaction with life as a whole refers to the question “Thinking about your own life and personal circumstances, how satisfied are you with your life as a whole 
in the past 4 weeks? Please use a scale ranging from 0 (completely dissatisfied) to 10 (completely satisfied)”. 
bSatisfaction with physical health refers to the question “How satisfied are you with your physical health in the past 4 weeks? Please use a scale ranging from 0 
(completely dissatisfied) to 10 (completely satisfied)”. 
cSatisfaction with psychological health, emotions and mood refers to the question ”How satisfied are you with your psychological health, emotions and mood in 
the past 4 weeks? Please use a scale ranging from 0 (completely dissatisfied) to 10 (completely satisfied)”.
TS24: Training Session 24.
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Pain
The prevalence of pain in the week prior to training 
(Fig. 1) was similar to frequencies reported in the 
literature (10). The pain experienced in the week prior 
to training and during training did not differ regarding 
type and location of pain. Relatively few participants 
experienced pain during training. This could indicate 
that the training did not provoke a new pain sensation 
and that the training was well tolerated. Kolakowsky-
Hayner (13) reported lower back pain during training 
with Ekso during walking, but this did not affect par-
ticipation. In our study, although reports of low back 
pain were documented as the most frequent location of 
pain, no individuals dropped out as a result of this (16). 
Case reports on improvements of pain after exoskeleton 
training have been published (12, 14, 32), as well as 
decrease in pain over time after training in the Lokomat 
(Hocoma AG, Zurich, Switzerland) (33), but changes 
over time in pain between training session were not 
found in our study. Differences in the findings in this 
study from previous findings could, however, be related 
to the method of pain assessment.
Spasticity
Spasticity did not change over the 8-week period, but 
decreased from before to after a training session at 
both TS12 and TS24. The sum-score values were in 
the lower end of the 0–60 sum-score scale. The reason 
for this was a high number of MAS ratings having a 
value of 0, i.e. no spasticity, since all values of the 12 
muscle groups were included in the sum-score. This 
indicates a floor effect, which biased the analysis of 
the training effect on spasticity. However, when listed 
as rank scores, all of the individual 12 muscle groups 
tested had more ranks that decreased than increased 
in MAS score at both TS12 and TS24.
Decreased spasticity post-training could be useful 
for individuals with SCI who would like to participate 
in exoskeleton training or use it as a potential, future 
mobility device. If used on a daily basis, it could, po-
tentially, be incorporated as part of a spasticity relief 
programme. Stampacchia et al. (25) found decreased 
spasticity, from pre- to post-training in 1 walking ses-
sion in a study of 21 participants. Case reports of short-
term improvements in spasticity of a few hours after 
training have also been published on the exoskeleton 
HAL (Hybrid Assistive Limb), Cyberdyne, Inc., Ibraki, 
Japan) (34). Thus, the results from the present study are 
in line with previous findings. 
The MAS was chosen as assessment method for 
spasticity. The MAS has several limitations as a 
measure of spasticity (35), but is still the most-used 
scale in the clinical setting (3). Furthermore, its use is 
recommended by the National Institute of Neurological 
Disorders and Stroke (NINDS) Common Data Element 
(CDE) (36). In a previous study, we found the MAS to 
be reliable, assuming that the scale is considered as an 
ordinal scale (37). The sum-score of MAS used in the 
analysis is not validated, but a similar approach with a 
sum-score of spasticity has been used previously (25). 
We argue that the sum-score could give an overall 
picture of the degree of lower limb spasticity. Future 
studies could consider adding other scales of spasticity 
alongside MAS to capture other aspects of spasticity. 
ROM was included as an end-point, in conjunction 
to the spasticity tests. In case there would have been 
changes in ROM, this could potentially confound the 
MAS assessment, but no change in ROM was found.
Spinal Cord Independence Measure, bowel and 
bladder function
The improvements seen in SCIM III for the recently 
injured group could probably be attributed to early 
phase improvements following SCI, especially con-
sidering that this group was relatively newly injured, 
with a median (IQR) time since injury of 0.3 (0.2–0.4) 
years (Table II). Interestingly, the results also indicated 
improvements for chronically injured participants on 
the total SCIM III score, although to a smaller degree. 
Respiration and sphincter management sub-score on 
SCIM III improved for both recently and chronically 
injured participants. There were signs of improvement 
in bowel function in the recently injured group on the 
SCIM III sub-score and in one item on the International 
SCI Bowel Function Basic Data Set, but not signifi-
cantly, within the chronically injured group. It can be 
speculated that a reason for not capturing a potential 
effect on bowel and LUT function was that the amount 
of training and intensity was too low to elicit changes. 
A recently published study by Hubscher et al. (38) 
documented improvements in urinary incontinence 
and time needed for defecation, assessed by the same 
questionnaires as in our study, following 80 daily loco-
motor training sessions using body-weight-supported 
treadmill training. 
There were, however, improvements on the SCIM 
III subscale “Use of Toilet”. We speculate whether this 
could be related to an improved balance function, since 
these participants also improved the Timed Up and 
Go test and the Berg Balance Scale in the same study 
period, as described previously (16). This could be a 
direction for future research. Previous studies on chan-
ges in bowel and bladder function after exoskeleton 
training has been documented in case reports (13, 14). 
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Furthermore, the QoL score increased in chronically 
injured participants. No significant changes were 
detected in bowel and LUT function. Future studies 
assessing bowel and LUT function could investigate a 
longer training period and higher frequency of training.
ACKNOWLEDGEMENTS
The authors would like to express their gratitude to all parti-
cipants in the study and thank the following therapists who 
took part in the training protocol and data collection: Mette 
Skov Henriksen and Mats Christer Nilfyr (Clinic for Spinal 
Cord Injuries, Rigshospitalet, University of Copenhagen, 
Hornbaek, Denmark); Michael Baumberger and Ines Bersch-
Porada (Swiss Paraplegic Centre (SPC), Nottwil, Switzerland); 
Sebastian Stallasch and Sebastian Lux (Universitäts- und 
Rehabilitationskliniken (RKU), Ulm, Germany); Esperanza 
Moreno and German Novillo (Fundación Lesionado Medular 
(FLM), Madrid, Spain); Niklas Fransson, Anna-Karin Hansson, 
Anna Granström and Mikael Lundgren (Clinical Department 
of Rehabilitation Medicine at Linköping University Hospital, 
Jönköping hospital and Västervik hospital, Sweden); Margareta 
Arnell and Peter Svensson (Spinal Cord Rehabilitation Unit, 
Uppsala University Hospital, Sweden); Ole Christian Andersen, 
Anna-Beth Netteland, Trygve Danielsen, Gyri S. Ingebretsen 
(Sunnaas Sykehus HF, Oslo, Norway); Eloy Opisso, Raquel 
Lopez, Josep Medina, Manel Ochoa and Eva Morales (Institut 
Guttmann, Neurorehabilitation Hospital, Barcelona, Spain); 
David Gobets, Mark van de Mijll Dekker, Ruth Sijsma (Helio-
mare Rehabilitation Center, Wijk aan Zee, The Netherlands). 
Finally, the authors would also like to thank Linda Jones, PT, 
MS, Consultant, for writing the initial protocol. 
Funding. Expenses at each of the participating centres were 
funded independently. External funds were provided by Stif-
telsen Promobilia, Region Östergötland and Medical Research 
Council of Southeast Sweden, which funded the Department 
of Rehabilitation Medicine and Department of Medical and 
Health Sciences, Linköping University, Linköping, Sweden. 
Uppsala University Hospital ALF funds funded the Spinal Cord 
Rehabilitation Unit, Uppsala University Hospital, Sweden. 
Sunnaasstiftelsen (The Sunnaas Foundation) funded Sunnaas 
Rehabilitation Hospital, Nesoddtangen, Norway. The remaining 
centres were funded by internal funds. Ekso Bionics provided 
an unconditional grant for protocol writing, salary for the Clini-
cal Study Lead and expenses related to the shared database to 
compile data across the 9 centres. 
Disclosure. Ekso GT provided an unconditional grant for 
protocol writing, salary for the Clinical Study Lead, Ulla Vig 
Nissen and expenses related to the shared database to compile 
data across the 9 centres. All other authors were supported by 
their institutions’ internal funds or independent funding grants.
Conflicts of interest. UVN received funding for salary in the 
study period from Ekso GT. All other authors have no conflicts 
of interest to declare.
REFERENCES
1. Anke AG, Stenehjem AE, Stanghelle JK. Pain and life 
quality within 2 years of spinal cord injury. Paraplegia 
1995; 33: 555–559.
2. Haisma JA, van der Woude LH, Stam HJ, Bergen MP, Sluis 
TA, Post MW, et al. Complications following spinal cord 
injury: occurrence and risk factors in a longitudinal study 
Quality of life
Chronically injured participants experienced an impro-
ved QoL “satisfaction with life as a whole” over the 
study period. This result was maintained throughout 
the follow-up period. Adriaansen et al. (10) reported 
a median value of 7 on the item “satisfaction with life 
as a whole”, a value of 6 on “satisfaction with physical 
health” and 7 on the item “satisfaction with psycho-
logical health” in a study on individuals with chronic 
SCI. Similar values on QoL were found in our study. 
Improvements in QoL have previous also been reported 
in case studies using the exoskeletons ReWalk (ReWalk 
Robotics Ltd, Yokneam, Israel (39) and HAL (32).
The recently injured group did not show any changes 
in QoL values in the present study. One explanation 
could be that QoL is known to improve in the years 
following the injury (7) and the recently injured group 
was only a few months post-injury.
The strengths of the current study include the hete-
rogeneous sample of participants with SCI, including 
participants with complete and incomplete injury, 
tetraplegia and paraplegia, recently and chronically 
injury and both sexes, across different rehabilitation 
centres and countries, reflecting the heterogeneous 
nature of the SCI population. However, this also limits 
the possibility to detect changes in the subgroups, 
since this would need a larger study population to 
fully explore all subgroup differences. Future studies 
could investigate whether more frequent and intense 
training protocols would elicit changes in, for example, 
pain, bowel and LUT function. The comparator in ran-
domized trials has often been body-weight-supported 
treadmill training, but also comparison with daily 
clinical routine treatment or even functional electric 
stimulation would be worth exploring, since the latter 
can be incorporated into exoskeletons. 
The study was a non-controlled, non-randomized stu-
dy with a sample of convenience, which does not allow 
conclusions to be drawn on causality of the findings in 
relation to the intervention of exoskeleton gait training. 
The results should be interpreted as indicators and can 
be used only to guide the direction of future studies. 
Conclusion 
The results of this study indicate that both recently 
injured and chronically injured participants can benefit 
from exoskeleton training. The exoskeleton training 
seemed to be well-tolerated in participants with pain 
and did not provoke new types of pain sensations. 
Spasticity decreased from before to after a training 
session, but did not change over time and there was 
no change in ROM. There was increase on SCIM III 
for both recently and chronically injured participants. 
www.medicaljournals.se/jrm
JR
M
JR
M
Jo
ur
na
l o
f 
R
eh
ab
ili
ta
ti
on
 M
ed
ic
in
e
JR
M
Jo
ur
na
l o
f 
R
eh
ab
ili
ta
ti
on
 M
ed
ic
in
e
813Exoskeleton gait training after SCI
during and after inpatient rehabilitation. J Rehabil Med 
2007; 39: 393–398.
3. Sköld C, Levi R, Seiger A. Spasticity after traumatic spinal 
cord injury: nature, severity, and location. Arch Phys Med 
Rehabil 1999; 80: 1548–1557.
4. Richards C, MacKenzie N, Roberts S, Escorpizo RD. People 
with spinal cord injury in the United States. Am J Phys 
Med 2017; 96: S124-S126.
5. Krassioukov A, Eng JJ, Claxton G, Sakakibara BM, Shum 
S. Neurogenic bowel management after spinal cord injury: 
a systematic review of the evidence. Spinal Cord 2010; 
48: 718–733.
6. Wyndaele J-J. The management of neurogenic lower uri-
nary tract dysfunction after spinal cord injury. Nat Rev 
Urol 2016; 13: 705–714.
7. Westgren N, Levi R. Quality of life and traumatic spinal 
cord injury. Arch Phys Med Rehabil 1998; 79: 1433–1439.
8. Anderson KD. Targeting recovery: priorities of the spi-
nal cord-injured population. J Neurotrauma 2004; 21: 
1371–1383.
9. Simpson LA, Eng JJ, Hsieh JTC, Wolfe DL. The health 
and life priorities of individuals with spinal cord injury: a 
systematic review. J Neurotrauma 2012; 29: 1548–1555.
10. Adriaansen JJE, Ruijs LEM, van Koppenhagen CF, van As-
beck FWA, Snoek GJ, van Kuppevelt D, et al. Secondary 
health conditions and quality of life in persons living with 
spinal cord injury for at least ten years. J Rehabil Med 
2016; 48: 853–860.
11. Jörgensen S, Ginis KA, Iwarsson S, Lexell J. Depressive 
symptoms among older adults with long-term spinal cord 
injury: associations with secondary health conditions, 
sense of coherence, coping strategies and physical activity. 
J Rehabil Med 2017; 49: 644–651.
12. Kressler J, Thomas CK, Field-Fote EC, Sanchez J, Wider-
ström-Noga E, Cilien DC, et al. Understanding therapeutic 
benefits of overground bionic ambulation: exploratory case 
series in persons with chronic, complete spinal cord injury. 
Arch Phys Med Rehabil 2014; 95: 1878–1887.
13. Kolakowsky-Hayner SA, Crew J, Moran S, Shah A. Safety 
and Feasibility of using the Ekso™ Bionic Exoskeleton to Aid 
Ambulation after Spinal Cord Injury. J Spine 2013; S4:003. 
14. Esquenazi A, Talaty M, Packel A, Saulino M. The ReWalk 
powered exoskeleton to restore ambulatory function to 
individuals with thoracic-level motor-complete spinal cord 
injury. Am J Phys Med Rehabil Assoc Acad Physiatr 2012; 
91: 911–921.
15. Palermo AE, Maher JL, Baunsgaard CB, Nash MS. Clinician-
focused overview of bionic exoskeleton use after spinal cord 
injury. Top Spinal Cord Inj Rehabil 2017; 23: 234–244.
16. Baunsgaard CB, Vig Nissen U, Katrin Brust A, Frotzler A, 
Ribeill C, Kalke Y-B, et al. Gait training after spinal cord 
injury: safety, feasibility and gait function following 8 
weeks of training with the exoskeletons from Ekso Bionics. 
Spinal Cord 2018; 56: 106–116.
17. International SCI Core Data Sets. 2016 [cited 2018 Apr 
15]. Available from: http://www.iscos.org.uk/internatio-
nal-sci-core-data-sets.
18. DeVivo M, Biering-Sørensen F, Charlifue S, Noonan V, Post 
M, Stripling T, et al. International Spinal Cord Injury Core 
Data Set. Spinal Cord 2006; 44: 535–540.
19. Mehrholz J, Kugler J, Pohl M. Locomotor training for 
walking after spinal cord injury. Cochrane Database Syst 
Rev 2012; 11: 1–49.
20. Waters RL, Yakura JS, Adkins RH, Sie I. Recovery follo-
wing complete paraplegia. Arch Phys Med Rehabil 1992; 
73: 784–789.
21. Waters RL, Adkins RH, Yakura JS, Sie I. Motor and sensory 
recovery following incomplete tetraplegia. Arch Phys Med 
Rehabil 1994; 75: 306–311.
22. Jacobs PL, Nash MS. Exercise recommendations for indivi-
duals with spinal cord injury. Sports Med Auckl NZ 2004; 
34: 727–751.
23. Miller LE, Zimmermann AK, Herbert WG. Clinical effective-
ness and safety of powered exoskeleton-assisted walking 
in patients with spinal cord injury: systematic review with 
meta-analysis. Med Devices Auckl NZ 2016; 9: 455–466.
24. Widerström-Noga E, Biering-Sørensen F, Bryce TN, Carde-
nas DD, Finnerup NB, Jensen MP, et al. The International 
Spinal Cord Injury Pain Basic Data Set (version 2.0). Spinal 
Cord 2014; 52: 282–286.
25. Stampacchia G, Rustici A, Bigazzi S, Gerini A, Tombini T, 
Mazzoleni S. Walking with a powered robotic exoskeleton: 
Subjective experience, spasticity and pain in spinal cord 
injured persons. NeuroRehabilitation 2016; 39: 277–283.
26. Anderson KD, Acuff ME, Arp BG, Backus D, Chun S, Fisher 
K et al. United States (US) multi-center study to assess 
the validity and reliability of the Spinal Cord Independence 
Measure (SCIM III). Spinal Cord 2011; 49: 880–885.
27. Anderson K, Aito S, Atkins M, Biering-Sørensen F, Charlifue 
S, Curt A et al. Functional recovery measures for spinal 
cord injury: an evidence-based review for clinical practice 
and research. J Spinal Cord Med 2008; 31: 133–144.
28. Krogh K, Perkash I, Stiens SA, Biering-Sørensen F. Inter-
national bowel function basic spinal cord injury data set. 
Spinal Cord 2009; 47: 230–234.
29. Biering-Sørensen F, Craggs M, Kennelly M, Schick E, Wyn-
daele J-J. International lower urinary tract function basic 
spinal cord injury data set. Spinal Cord 2008; 46: 325–330.
30. Charlifue S, Post MW, Biering-Sørensen F, Catz A, Dijkers 
M, Geyh S, et al. International Spinal Cord Injury Quality 
of Life Basic Data Set. Spinal Cord 2012; 50: 672–675.
31. Biering-Sørensen F, Alexander MS, Burns S, Charlifue S, 
DeVivo M, Dietz V, et al. Recommendations for translation 
and reliability testing of international spinal cord injury 
data sets. Spinal Cord 2011; 49: 357–360.
32. Cruciger O, Schildhauer TA, Meindl RC, Tegenthoff M, 
Schwenkreis P, Citak M, et al. Impact of locomotion training 
with a neurologic controlled hybrid assistive limb (HAL) 
exoskeleton on neuropathic pain and health related quality 
of life (HRQoL) in chronic SCI: a case study. Disabil Rehabil 
Assist Technol 2016; 11: 529–534.
33. Labruyère R, van Hedel HJA. Strength training versus robot-
assisted gait training after incomplete spinal cord injury: 
a randomized pilot study in patients depending on walking 
assistance. J NeuroEngineering Rehabil 2014; 11: 4.
34. Aach M, Cruciger O, Sczesny-Kaiser M, Höffken O, Meindl 
RC, Tegenthoff M, et al. Voluntary driven exoskeleton as 
a new tool for rehabilitation in chronic spinal cord injury: 
a pilot study. Spine J Off J North Am Spine Soc 2014; 14: 
2847–2853.
35. Pandyan AD, Johnson GR, Price CI, Curless RH, Barnes MP, 
Rodgers H. A review of the properties and limitations of 
the Ashworth and modified Ashworth Scales as measures 
of spasticity. Clin Rehabil 1999; 13: 373–383.
36. NIH commen data elements. 2018 [cited 2018 May 14]. 
Available from: http://www.commondataelements.ninds.
nih.gov/SCI.aspx#tab=Data_Standards.
37. Baunsgaard CB, Nissen UV, Christensen KB, Biering-
Sørensen F. Modified Ashworth scale and spasm frequency 
score in spinal cord injury: reliability and correlation. 
Spinal Cord 2016; 54: 702–708.
38. Hubscher CH, Herrity AN, Williams CS, Montgomery LR, 
Willhite AM, Angeli CA, et al. Improvements in bladder, 
bowel and sexual outcomes following task-specific loco-
motor training in human spinal cord injury. PLoS ONE 
2018; 13: 1–26. 
39. Raab K, Krakow K, Tripp F, Jung M. Effects of training with 
the ReWalk exoskeleton on quality of life in incomplete 
spinal cord injury: a single case study. Spinal Cord Ser 
Cases 2016; 2: 15025.
J Rehabil Med 50, 2018
